Second part of very important #COVI Committee exchange with @GSK, @Novavax and #HIPRA. We need to continue doing our utmost so that EU remains a competitive place for R&D and innovation, ensure its #StrategicAutonomy & provide citizens with a broad vaccine portfolio.

@EPPGroup

🐦🔗: https://nitter.eu/Kympouropoulos/status/1579502843241050114